Increased Flexibility Seen in Preapproval Evidence for New Drugs
WEDNESDAY, May 18, 2022 -- The characteristics of acceptable preapproval evidence were more flexible for novel drugs approved by the U.S. Food and Drug Administration in 2020, according to a research letter published online May 17 in JAMA Network...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Food and Drug Administration (FDA) | Pharmaceuticals